Norofert SA

Norofert's capital structure is characterized by a debt-to-equity ratio of 1.56, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with a current ratio of 1.48, suggesting it can cover short-term obligations but with limited buffer. Free cash flow is negative at -3.41 million RON, and capital expenditures of -8.84 million RON indicate ongoing investment in operations. Profitability metrics show a return on equity (ROE) of 13.08% and a return on assets (ROA) of 3.69%, both below the industry median for Agricultural Chemicals. The gross profit margin is 41.3%, and the operating margin is 15.6%, which are in line with the sector but suggest limited pricing power or cost control advantages. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory shifts, particularly in the Romanian market. Growth trajectory is constrained by negative free cash flow and high capital expenditures. The company has not disclosed revenue growth rates for the past three years, but the negative cash flow from operations and high debt load suggest limited capacity for organic expansion without external financing. Risk factors include a medium liquidity risk due to the current ratio and negative net cash position after subtracting total debt. Dilution risk is assessed as low, with no recent share issuance or shelf registration activity reported. However, the company's reliance on long-term debt (38.7 million RON) could increase refinancing risk in a rising interest rate environment. Recent filings and transcripts do not indicate any material events or strategic shifts. The company's 10-K filing highlights ongoing investment in production capacity and supply chain optimization, but no new product launches or market expansions were disclosed.